HOLY S**T16 Jun 2020 14:29
Just struck me, this has nothing to do with Covid-19
This is on the back of the HCV test kit.
Genedrive
Intervention: Diagnostic
Targets: Tuberculosis (TB), HCV
GHIF Financing: $8.0 million convertible bond
Impact Objectives: Diagnosis of TB and HCV on a near-point-of-care molecular diagnostic platform, enabling more effective treatment